First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|
Assets | |||||||
Cash And Cash Equivalents At Carrying Value | 168 | 248 | |||||
Assets Current | |||||||
Assets Current | 178 | 289 | |||||
Available For Sale Securities Debt Securities Curr… | 0 | 38 | |||||
Prepaid Expense And Other Assets Current | 10 | 3 | |||||
Property Plant And Equipment Net | 1 | 1 | |||||
Operating Lease Right Of Use Asset | 4 | 0 | |||||
Other Assets Noncurrent | 0 | 0 | |||||
Assets | 183 | 291 | |||||
Liabilities And Stockhold… | |||||||
Accounts Payable Current | 3 | 7 | |||||
Liabilities Current | |||||||
Accrued Liabilities Current | 7 | 26 | |||||
Liabilities Current | 12 | 33 | |||||
Operating Lease Liability Current | 2 | 0 | |||||
Operating Lease Liability Noncurrent | 2 | 0 | |||||
Members Capital | 0 | 258 | |||||
Stockholders Equity | |||||||
Stockholders Equity | 169 | 257 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | -0 | |||||
Liabilities And Stockholders Equity | 183 | 291 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month |
|---|---|---|---|---|---|---|
| 2026 | -8.59% | 6.28% | 163.11% | - | - | - |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
First Tracks Biotherapeutics, Inc. (TRAX) — SEC Financial Statements & Analysis
First Tracks Biotherapeutics, Inc. (TRAX) is a pharmaceutical preparations company, incorporated in DE. First Tracks Biotherapeutics, Inc. trades on Nasdaq as: TRAX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), First Tracks Biotherapeutics, Inc. reported a Debt-to-Equity ratio of 0.07x, a Price-to-Book (P/B) ratio of 4.17x (TTM), at a market cap of $704.26M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.07x
- P/B TTM
- 4.17x
- Market Cap
- $704.26M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is First Tracks Biotherapeutics, Inc. in?
First Tracks Biotherapeutics, Inc. (TRAX) operates in the Pharmaceutical Preparations industry.
What is TRAX's market cap?
First Tracks Biotherapeutics, Inc. (TRAX) has a market capitalization of $704.26M as of 2026-06-30.
What exchange does TRAX trade on?
First Tracks Biotherapeutics, Inc. (TRAX) trades on the Nasdaq.
Where is First Tracks Biotherapeutics, Inc. incorporated?
First Tracks Biotherapeutics, Inc. is incorporated in DE.